Enamine's IDD Platform Accelerates Nuclide Therapeutics' Precision Radiotheranostics Pipeline Towards the Clinic
Nuclide Therapeutics Leverages Enamine's Deep Expertise in Rapid and Scalable Synthesis of Small Molecules KYIV, UKRAINE, April 2, 2026 /EINPresswire.com/ -- Nuclide Therapeutics and Enamine initiated their cooperation in 2025. Since then, Enamine …